Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report
AbstractThe pathogenetic role of TNFα in inflammatory diseases has been known for a long time and has modified the therapeutic approach towards this pathology. All over the word, about 400.000 patients have been treated with biological anti-TNFα drugs. Particular attention has been taken for the safety of their use. Let us describe a case of 60 year old man affected by rheumatoid arthritis who has developed nephrotic syndrome with histological pattern typical of systemic lupus erythematosus-like syndrome, without autoantibodies.
- Abstract views: 863
- PDF: 605
Copyright (c) 1970 M.G. Portuesi, P. Perosa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.